Literature DB >> 29172729

Association of insulin resistance and autonomic tone in patients with pregnancy-induced hypertension.

Jing Guo1, Guanghui Liu2, Gang Guo3.   

Abstract

Pregnancy-induced hypertension (PIH) remains the main cause of maternal and fatal mortality. Insulin resistance (IR) and autonomic nervous system (ANS) imbalance are two principal drivers of PIH development. Few previous researches investigated the association between IR and ANS imbalance in Chinese PIH patients. 120 pregnant women were enrolled in our study, sixty healthy pregnant women (control group), fourty one gestational hypertension (GH group) and nineteen preeclampsia patients (PE group). The homeostasis model assessment of IR (HOMA-IR) and markers of ANS (plasma biomarkers and heart rate variability (HRV) components) were collected. Body mass index (BMI), Ln(HOMA-IR), noradrenaline level, LnTP (total power), Ln SDNN (standard deviation of the normal-to-normal interval), LnLF (low frequency), LnLF/LnHF (low frequency/high frequency) were different in the GH and PE groups compared with the controls. Significant correlations were observed between Ln (HOMA-IR) and gestational duration (r = 0.237, P = 0.031), BMI(r = 0.314, P = 0.002), systolic blood pressure (r = 0.108, P = 0.016), noradrenaline (r = 0.451, P = 0.009), LnTP (r = -0.269, P = 0.015) and LnLF/HF (r = 0.183, P = 0.026) in those PIH patients. Furthermore, BMI, noradrenaline and LnTP were independent determinants of Ln(HOMA-IR) in PIH patients by multiple regression analysis. Our finding verified both IR and ANS imbalance were more severe in PIH patients than healthy pregnant women. Moreover, IR had a close association with ANS parameters in PIH patients, suggesting that they probably had contributory effects on the occurrence and development of PIH. We propose that these parameters could be added to the traditional indexes for individualized treatment of PIH patients in the future.

Entities:  

Keywords:  Insulin resistance; autonomic activities; heart rate variability; preeclampsia; pregnancy-induced hypertension

Mesh:

Substances:

Year:  2017        PMID: 29172729     DOI: 10.1080/10641963.2017.1403619

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  5 in total

1.  Association of pre-pregnancy subclinical insulin resistance with cardiac dysfunction in healthy nulliparous women.

Authors:  Rachel B C Psoinos; Erin A Morris; Carole A McBride; Ira M Bernstein
Journal:  Pregnancy Hypertens       Date:  2021-07-23       Impact factor: 2.899

2.  The Relationship between Angiogenic Factors and Energy Metabolism in Preeclampsia.

Authors:  Alejandra Abascal-Saiz; Marta Duque-Alcorta; Victoria Fioravantti; Eugenia Antolín; Eva Fuente-Luelmo; María Haro; María P Ramos-Álvarez; Germán Perdomo; José L Bartha
Journal:  Nutrients       Date:  2022-05-23       Impact factor: 6.706

3.  Blood glucose related to pregnancy induced hypertension syndrome.

Authors:  Zhao Zhou; Cuiyan Deng; Xuewen Xiang
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

4.  Assessment of plasma cell-free DNA and ST2 as parameters in gestational hypertension and preeclampsia.

Authors:  Lisheng Liu; Hua Li; Ning Wang; Xingguo Song; Ke Zhao; Cong Zhang
Journal:  Hypertens Res       Date:  2021-04-16       Impact factor: 3.872

Review 5.  L-Carnitine's Effect on the Biomarkers of Metabolic Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Munji Choi; Seongmin Park; Myoungsook Lee
Journal:  Nutrients       Date:  2020-09-12       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.